Inhibitory Effects of Dietary Curcumin on Forestomach, Duodenal, and Colon Carcinogenesis in Mice

Cancer Research

Volumn 54, Issue 22, 1994, Pages 5841-5847

  Reuhl, Kenneth R ^a   Lou, You Rong ^a   Ma, Wei ^a   Newmark, Harold L ^a   Conney, Allan H ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BENZO[A]PYRENE; CURCUMIN; ETHYLNITRONITROSOGUANIDINE;

ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CHEMICAL CARCINOGENESIS; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; DIET THERAPY; DUODENUM; DUODENUM CANCER; FEMALE; FORESTOMACH; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOGENESIS;

ADENOCARCINOMA; ADENOMA; ADENOMA, VILLOUS; ANIMALS; AZOXYMETHANE; BENZO(A)PYRENE; CARCINOGENS; COLONIC NEOPLASMS; CURCUMIN; DUODENAL NEOPLASMS; FEMALE; MALE; METHYLNITRONITROSOGUANIDINE; MICE; STOMACH NEOPLASMS;

EID: 0028073507     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Doll, R. and Peto, R. The causes of cancer: quantitative estimates of avoidable risks of cancer in United States today. J. Natl. Cancer Inst. 66: 1191-1308, 1981.
2. Doll, R. The lessons of life: keynote address to the nutrition and cancer conference. Cancer Res. 52: 2024s-2029s, 1992.
3. Wattenberg, L.W. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. 52: 2085s-2091s, 1992.
4. Kraemer, K.H. DiGiovanna, J.J. Moshell, A.N. Tarone, R.E. and Peck, G.L. Prevention of skin cancer in xeroderma pigmentosum with use of oral isotretinoin. N. Engl. J. Med. 318: 1633-1637, 1988.
5. Hong, W.K. Lippman, S.M. Itri, M. Karp, D.D. Lee, J.S. Byers, R. Schantz, S.P. Kramer, B.W. Lotan, R. Peters, L.J. Dimery, I.W. Brown, B.W. and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 323: 795-801, 1990.
6. Blot, W.J. Li, J.Y. Taylor, P.R. Guo, W. Dawsey, S. Wang, G.Q. Yang, C.S. Zhang, S.F. Gail, M. Li, G.Y. Yu, Y. Liu, B.Q. Tangrea, J. Sun, Y.H. Liu, F. Fraumeni, J.F.J. Zhang, Y.H. and Li, B. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst. 85: 1483-1491, 1993.
7. Ammon, H.P.T. and Wahl, M.A. Pharmacology of Curcuma longa. Planta Med. 57: 1-7, 1990.
8. Govindarajan, V.S. Turmeric chemistry, technology and quality. CRC Rev. Food Sci. Nutr, 12: 199-301, 1980.
9. Huang, M.T. Robertson, F.M. Lysz, T. Ferrara, T. Wang, Z.Y. Georgiadis, C.A. Laskin, J.D. and Conney, A.H. Inhibitory effects of curcumin on carcinogenesis in mouse epidermis. In: M.T. Huang, C.T. Ho, and C.Y. Lee (eds.), Phenolic Compounds in Food and Their Effects on Health II: Antioxidants and Cancer Prevention, pp. 339-349. Washington, DC.: American Chemical Society, 1992.
10. Tonnesen, H.H. Chemistry, stability and analysis of curcumin, a naturally occurring drug molecule. Ph.D. Dissertation, The Institute of Pharmacy, University of Oslo, 1988.
11. Huang, M.T. Smart, R.C. Wong, C.Q. and Conney, A.H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48: 5941-5946, 1988.
12. Lu, Y.P. Chang, R.L. Huang, M.T. and Conney, A.H. Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis (Lond.), 14: 293-297, 1993.
13. Huang, M.T. Lysz, T. Ferrara, T. Abidi, T.F. Laskin, J.D. and Conney, A.H. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51: 813-819, 1991.
14. Flynn, D.L. Rafferty, M.F. and Boctor, A.M. Inhibition of 5-hydroxyeicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally occurring diarylheptanoids: Inhibitory activities of curcuminoids and yakuchinones. Leukotrienes Med. 22: 357-360, 1986.
15. Huang, M.T. Wang, Z.Y. Georgiadis, C.A. Laskin, J.D. and Conney, A.H. Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7, 12-dimethylbenz[a]anthracene. Carcinogenesis (Lond.), 13: 2183-2186, 1992.
16. Huang, M.T. Deschner, E.E. Newmark, H.L. Wang, Z.Y. Ferrara, T.A. and Conney, A.H. Effect of dietary curcumin and ascorbyl palmitate on azoxymethanolinduced colonic epithelial cell proliferation and focal areas of dysplasia. Cancer Lett. 64: 117-121, 1992.
17. Wattenberg, L.W. Inhibitory effects of benzyl isothiocyanate administered shortly before dimethylnitrosamine or benzo[a]pyrene on pulmonary and forestomach neoplasia in A/J mice. Carcinogenesis (Lond.), 5: 1971-1973, 1987.
18. Fujita, Y. Yamane, T. Tanaka, M. Kuwata, K. Okuzumi, J. Takahahi, T. Fujiki, H. and Okuda, T. Inhibitory effect of (-)-epigallocatechin gallate on carcinogenesis with N-ethyl-N’-nitro-N-nitrosoguanidine in mouse duodenum. Jpn. J. Cancer Res. 80: 503-505, 1989.
19. Deschner, E E. Ruperto, J. Wong, G. and Newmark, H.L. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis (Lond.), 12: 1193-1196, 1991.
20. Wang, Z.Y. Huang, M.T. Ho, C.T. Chang, R.L. Ma, W. Ferraro, T. Reuhl, K.R. Yang, C S. and Conney, A.H. Effects of green tea on the growth of established skin papillomas in mice. Cancer Res. 52: 6657-6665, 1992.
21. WHO International Agency for Research on Cancer. Tumours of the Intestines. IARC Scientific Publications No. 5, Vol. 1, Part 1, pp. 119-168. Geneva: WHO, 1973.
22. WHO International Agency for Research on Cancer. Tumours of oral cavity, pharynx, oesophagus and stomach, and tumours of the intestines and peritoneum. IARC Scientific Publications, No. 23, Vol. 2, pp. 149-151, 169-176, 1979.
23. Huang, M.T. Ma, W. Lou, Y.R. Wang, Z.Y. Lu, Y.P. Chang, R.L. Newmark, H. Marchand, P. and Conney, A.H. Effects of derivatives of curcumin on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced tumor promotion in mouse epidermis and anchorage-independent growth of cultured JB6 cells. Proc. Am. Assoc. Cancer Res. 33: 166, 1992.
24. Mukundan, M.A. Chacko, M.C. Annapurna, V.V. and Krishnaswamy, K. Effect of tunneric and curcumin on BP-DNA adducts. Carcinogenesis (Lond.), 14: 493-496, 1993.
25. Azuine, M.A. and Bhide, S.V. Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr. Cancer, 17: 77-83, 1992.
26. Lahiri, M. Mam, G.B. Amonkar, A.J. and Bhide, S.V. Modulation of benzo-[a]pyrene induced DNA damage by some chemopreventive agents. In: S.V. Bhide and G.B. Maru (eds.), Chemoprevention of Cancer, pp. 152-161. New Delhi: Omega Scientific Publishers, 1992.
27. Polasa, K. Averback, D. and Krishnaswamy, K. Studies on the influence of curcumin on the induction and repair of DNA single strand breaks (SSb) produced by genotoxic agents. Mutat Res. in press, 1994.
28. Smart, R.G. Huang, M.T. Han, Z.T. Kaplan, M.C. Focella, A. and Conney, A.H. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of ornithine decarboxylase activity, DNA synthesis, and tumor promotion in mouse skin by ascorbic acid and ascorbyl palmitate. Cancer Res. 47: 6633-6638, 1987.
29. Frenkel, K. Wei, H. Bhimani, R. Ye, J. Zadunaisky, J.A. Huang, M.T. Ferraro, T. Conney, A.H. and Grunberger, D. Inhibition of tumor promoter-mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester. Cancer Res. 53: 1255-1261, 1993.
30. McCormick, D.L. Major, N. and Moon, R.C. Inhibition of 7, 12-dimethylbenz[a]-anthracene-induced rat mammary carcinogenesis by concomitant or post-carcinogenesis antioxidant exposure. Cancer Res. 44: 2858-2863, 1984.
31. Fiala, E.S. Reddy, B.S. and Weisburger, J.H. Naturally occurring anti-carcinogenic substances in foodstuffs. Annu. Rev. Nutr. 5: 295-321, 1985.
32. Srimal, R.C. and Dhawan, B.N. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol. 25: 447-452, 1973.
33. Rao, T.S. Basu, N. and Siddiqui, H.H. Anti-inflammatory activity of curcumin analogues. Indian J. Med. Res. 75: 574-578, 1982.
34. Kunchandy, E. and Rao, M.N.A. Oxygen radical scavenging activity of curcumin. Inter. J. Pharmaceut. 58: 237-240, 1990.
35. Marnett, L.J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 52: 5575-5589, 1992.
36. Reddy, B.S. Rao, C.V. Rivenson, A. and Kelloff, G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis (Lond.), 14: 1493-1497, 1993.
37. Reddy, B.S. Maruyama, H. and Kelloff, G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug during different stages of rat colon tumor development. Cancer Res. 47: 5340-5346, 1987.
38. Pollard, M. and Luckert, P.H. Indometacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treat. Rep. 64: 1323-1327, 1980.
39. Narisawa, T. Takahashi, M. Niwa, M. Fukaura, Y. and Wakizaka, A. Involvement of prostaglandin E in bile acid-caused promotion of colon carcinogenesis and antipromotion by the cyclooxygenase inhibitor indomethacin. Jpn. J. Cancer Res. 78: 791-798, 1987.
40. Waddell, W.R. and Loughry, R.W. Sulindac for polyposis of the colon. J. Surg. Oncol. 24: 83-87, 1983.
41. Waddell, W.R. Gasner, G.F. Cerise, E.J. and Loughry, R.W. Sulindac for polyposis of colon. Am. J. Surg. 157: 175-178, 1989.
42. Rigau, J. Pique, J.M. Rubio, E. Planas, R. Tarrech, J.M. and Bordas, J.M. Effects of long-term sulindac therapy on colonic polyposis. Ann. Intern. Med. 115: 952-955, 1991.
43. Kune, G.A. Kune, S. and Watson, L.F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 48: 4399-4404, 1988.
44. Thun, M.J. Namboodiri, M.M. and Heath, C.W. Jr. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325: 1593-1596, 1991.
45. Rosenberg, L. Palmer, J.R. Zauber, A.G. Warshauer, M.E. Stolley, P.D. and Shapiro, A. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J. Natl. Cancer Inst. 83: 355-358, 1991.
46. Labayle, D. Fischer, D. Vielh, P. Drouhin, F. Pariente, A. Bories, C. Duhamel, O. Trousset, M. and Attali, P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101: 635-639, 1991.
47. Rao, C.V. Simi, B. and Reddy, B.S. Inhibitory effect by dietary curcumin of azoxymethane-induced ornithine carboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis (Lond.), 14: 2219-2225, 1993.
48. Ravindranath, V. and Chandrasekhara, N. Absorption and tissue distribution of curcumin in rats. Toxicology, 16: 259-265, 1980.
49. Wahlstrom, B. and Blennow, G. A study on the fate of curcumin in the rat. Acta Pharmacol. Toxicol. 43: 86-92, 1978.
50. Ravindranath, V. and Chandrasekhara, N. Metabolism of curcumin-studies with [3H]curcumin. Toxicology, 22: 337-344, 1982.
51. Bille, N. Larsen, J.C. Hansen, E.V. and Wurtzen, G. Subchronic oral toxicity of turmeric oleoresin in pigs. Food Chem. Toxicol. 23: 967-971, 1985.
52. Thimmayamma, B.V.S. Rao, P. and Radhaiah, G. Use of spices and condiments in the diets of urban/rural families. Indian J. Nutr. Diet. 20: 153-162, 1983.